Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes

Jorge Cortes, Stefan Faderl, Elihu Estey, Razelle Kurzrock, Deborah Thomas, Miloslav Beran, Guillermo Garcia-Manero, Alessandra Ferrajoli, Francis Giles, Charles Koller, Susan O'Brien, John Wright, Stephen A. Bai, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences